The impact of the degree of myocardial injury after transcatheter aortic valve implantation on left ventricle function after TAVI and predictors of myocardial injury after transcatheter aortic valve implantation: SAPIEN 3 study
Not Applicable
- Conditions
- aortic valve stenosis
- Registration Number
- JPRN-UMIN000036669
- Lead Sponsor
- Tachikawa general hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
Not provided
Exclusion Criteria
the use of dialysis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link myocardial injury to left ventricular dysfunction after TAVI in aortic stenosis patients?
How does SAPIEN 3 valve performance compare to surgical aortic valve replacement in terms of post-procedural myocardial injury biomarkers?
Which biomarkers predict severity of myocardial injury following transcatheter aortic valve implantation in elderly patients?
What are the key adverse events associated with SAPIEN 3 TAVI in aortic valve stenosis and their management strategies?
How do procedural parameters influence myocardial injury outcomes in JPRN-UMIN000036669 TAVI study?